Newsroom

LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (NASDAQ: HOPE) (the “Company”), the holding company of Bank of Hope (the “Bank”), today announced that Scott Yoon-Suk Whang has elected not to stand for re-election and will be retiring from his position as a member of the Boards of Directors of the Company and the Bank in connection with the Company’s 2026 Annual Meeting of Stockholders. “On behalf of the Board, I would like to thank Director Whang for his many years of service and dedication,”...

GLEN ALLEN, Va.--(BUSINESS WIRE)--Dynex Capital, Inc. (NYSE: DX) announced today that it will release its financial results for the fourth quarter and full year 2025 before market open and will host a conference call and live audio webcast to discuss its financial results at 10:00 a.m. ET on Monday, January 26, 2026. Webcast Details The live audio webcast will be accessible online at www.dynexcapital.com on the Investors page. An archive of the webcast will be available on the Company website a...

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating (FSR) of A++ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “aa+” (Superior) of the grouped subsidiaries of Chubb Limited (Chubb) (Zurich, Switzerland) [NYSE: CB]. These include Chubb’s rated U.S., Canada, Bermuda, Europe and Panama-based insurance and reinsurance subsidiaries (collectively Chubb Group of Insurance Companies, or Chubb Group). Concurrently, AM Best has affirmed the Long-Term...

NEW YORK--(BUSINESS WIRE)--Announcement of Mesabi Trust Distribution The Trustees of Mesabi Trust (NYSE:MSB) declared a distribution of twenty-six cents ($0.26) per Unit of Beneficial Interest payable on February 20, 2026 to Mesabi Trust Unitholders of record at the close of business on January 30, 2026. This compares to a five dollar ninety-five cents ($5.95) per Unit distribution declared for the same period last year. The Trustees’ announcement today of a twenty-six cents ($0.26) per Unit di...

NEW YORK--(BUSINESS WIRE)--Metropolitan Bank Holding Corp. (the “Company”) (NYSE: MCB), the holding company for Metropolitan Commercial Bank, today announced a quarterly cash dividend of $0.20 per share on the Company’s common stock (the “Dividend”), an increase of $0.05 from the prior quarterly dividend of $0.15 per share. The Dividend is payable on February 6, 2026 to holders of record of the Company’s common stock at the close of business on January 27, 2026. About Metropolitan Bank Holding...

ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on January 12, 2026, the Compensation Committee of Cardlytics’ Board of Directors granted an aggregate of 1,000,000 restricted stock units of Cardlytics to its newly appointed Chief Financial Officer, David Evans. The restricted stock units were granted as a material inducement to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement P...

MILWAUKEE--(BUSINESS WIRE)--The Board of Directors of Sensient Technologies Corporation (NYSE: SXT) has declared a regular quarterly cash dividend on its common stock of $0.41 per share. The cash dividend will be paid on March 2, 2026, to shareholders of record on February 3, 2026. About Sensient Technologies Sensient Technologies Corporation is a leading global manufacturer and marketer of colors, flavors, and other specialty ingredients. Sensient uses advanced technologies and robust global s...

LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to two new employees. On January 15, 2026, the Compensation Committee of Savara's Board of Directors granted the inducement awards to two new employees who recently joined the Company. The inducement awards consist of options to purchase an aggregate of 17,500 shares of the Company’s common stock and restrict...

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on January 15, 2026, it granted stock options to purchase an aggregate of 74,020 shares of common stock to nine...

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that on January 15, 2026, inducement grants (the “Inducement Grants”) were made to four employees in connection with the commencement of their employment. The Inducement Grants consist of 88,050 restricted stock units (“RSUs”) representing 88,050 shares of Quanterix common...